Related Experiment Video

Updated: Aug 5, 2026

Screening Ion Channels in Cancer Cells
06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Hydrogel-Based Delivery of Ion Channel Modulators for Cancer Therapy: Current Advances and Future Perspectives

Gizem Ozkurnaz Civir1, Ilknur Atli2, Ozgur Ozay3

  • 1Department of Plant and Animal Production, Lapseki Vocation School, Çanakkale Onsekiz Mart University, 17800 Çanakkale, Türkiye.

Gels (Basel, Switzerland)
|July 27, 2026
PubMed

Insights

Novel cancer treatments leverage ion channel modulators delivered via hydrogels to improve drug efficacy. This review explores their antitumor potential, delivery advantages, and clinical limitations for innovative therapeutic strategies.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Pharmacology

Background:

  • Cancer is a leading global health challenge with treatment limitations.
  • Ion channels regulate critical cellular processes, including proliferation and cell death.
  • Targeting ion channels shows promise for novel cancer therapies.

Purpose of the Study:

  • To review the antitumor effects of ion channel modulators.
  • To evaluate hydrogel-based drug delivery systems for these modulators.
  • To discuss the clinical potential and limitations of this approach.

Main Methods:

  • Literature review of ion channel modulators in cancer treatment.
  • Analysis of hydrogel properties for drug delivery.
  • Evaluation of pharmacokinetic and biocompatibility data.

Main Results:

  • Ion channel modulators demonstrate significant potential in suppressing tumor growth.
  • Hydrogels offer advantages like controlled release and targeted delivery.
  • Biocompatibility and stability are key considerations for clinical translation.

Conclusions:

  • Hydrogel-based delivery enhances the efficacy of ion channel modulators for cancer treatment.
  • Further research is needed to overcome clinical limitations and optimize therapeutic strategies.
  • This approach presents innovative perspectives for addressing unmet needs in cancer therapy.
Keywords:
cancerdrug deliveryhydrogelion channel modulators

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.